Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | +2.77% | +3.80% | +118.60% |
04-17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
04-10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.60% | 854M | |
+24.66% | 44.96B | |
+1.18% | 42.65B | |
+45.89% | 41.85B | |
-4.27% | 29.04B | |
+11.10% | 26.08B | |
-20.70% | 19.03B | |
+5.88% | 12.75B | |
+28.14% | 12.06B | |
-3.66% | 11.75B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- BTIG Upgrades Nuvation Bio to Buy From Neutral, Price Target is $5